Wells Fargo’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.3M | Buy |
127,134
+7,796
| +7% | +$1.44M | ﹤0.01% | 1414 |
|
|
2025
Q4 | $21M | Sell |
119,338
-56,926
| -32% | -$9.3M | ﹤0.01% | 1464 |
|
|
2025
Q3 | $24.7M | Buy |
176,264
+10,302
| +6% | +$1.39M | ﹤0.01% | 1346 |
|
|
2025
Q2 | $20.8M | Buy |
165,962
+11,477
| +7% | +$1.43M | ﹤0.01% | 1378 |
|
|
2025
Q1 | $21.1M | Buy |
154,485
+43,442
| +39% | +$6.21M | ﹤0.01% | 1296 |
|
|
2024
Q4 | $17M | Sell |
111,043
-95,427
| -46% | -$16.1M | ﹤0.01% | 1463 |
|
|
2024
Q3 | $40M | Sell |
206,470
-41,290
| -17% | -$8.64M | 0.01% | 905 |
|
|
2024
Q2 | $57.4M | Buy |
247,760
+26,684
| +12% | +$5.8M | 0.01% | 710 |
|
|
2024
Q1 | $47.7M | Sell |
221,076
-10,375
| -4% | -$2.43M | 0.01% | 781 |
|
|
2023
Q4 | $59.9M | Buy |
231,451
+16,778
| +8% | +$4.12M | 0.02% | 660 |
|
|
2023
Q3 | $55.2M | Sell |
214,673
-35,155
| -14% | -$9.4M | 0.02% | 640 |
|
|
2023
Q2 | $71.2M | Sell |
249,828
-5,194
| -2% | -$1.55M | 0.02% | 578 |
|
|
2023
Q1 | $70.9M | Sell |
255,022
-11,086
| -4% | -$3.07M | 0.02% | 555 |
|
|
2022
Q4 | $73.7M | Sell |
266,108
-52,870
| -17% | -$14.9M | 0.02% | 530 |
|
|
2022
Q3 | $85.2M | Sell |
318,978
-40,101
| -11% | -$8.52M | 0.03% | 443 |
|
|
2022
Q2 | $73.2M | Sell |
359,079
-80,651
| -18% | -$16.5M | 0.02% | 519 |
|
|
2022
Q1 | $92.6M | Buy |
439,730
+38,751
| +10% | +$8.43M | 0.02% | 516 |
|
|
2021
Q4 | $96.2M | Sell |
400,979
-172,597
| -30% | -$44.4M | 0.02% | 505 |
|
|
2021
Q3 | $162M | Buy |
573,576
+23,940
| +4% | +$7.85M | 0.04% | 464 |
|
|
2021
Q2 | $190M | Sell |
549,636
-31,100
| -5% | -$9.42M | 0.04% | 415 |
|
|
2021
Q1 | $162M | Sell |
580,736
-17,943
| -3% | -$4.84M | 0.04% | 459 |
|
|
2020
Q4 | $147M | Sell |
598,679
-153,694
| -20% | -$39.6M | 0.04% | 480 |
|
|
2020
Q3 | $213M | Buy |
752,373
+7,649
| +1% | +$2.13M | 0.06% | 315 |
|
|
2020
Q2 | $199M | Buy |
744,724
+42,187
| +6% | +$12.7M | 0.06% | 314 |
|
|
2020
Q1 | $222M | Sell |
702,537
-131,668
| -16% | -$40M | 0.08% | 247 |
|
|
2019
Q4 | $248M | Sell |
834,205
-13,213
| -2% | -$3.67M | 0.07% | 287 |
|
|
2019
Q3 | $197M | Sell |
847,418
-2,838
| -0.3% | -$661K | 0.06% | 349 |
|
|
2019
Q2 | $199M | Sell |
850,256
-101,332
| -11% | -$23.4M | 0.06% | 334 |
|
|
2019
Q1 | $225M | Sell |
951,588
-104,981
| -10% | -$33.1M | 0.07% | 286 |
|
|
2018
Q4 | $318M | Buy |
1,056,569
+50,469
| +5% | +$16.1M | 0.11% | 191 |
|
|
2018
Q3 | $355M | Sell |
1,006,100
-42,527
| -4% | -$14.6M | 0.1% | 197 |
|
|
2018
Q2 | $304M | Buy |
1,048,627
+33,848
| +3% | +$9.52M | 0.09% | 226 |
|
|
2018
Q1 | $278M | Sell |
1,014,779
-135,698
| -12% | -$42.1M | 0.08% | 249 |
|
|
2017
Q4 | $367M | Buy |
1,150,477
+174,485
| +18% | +$56M | 0.11% | 190 |
|
|
2017
Q3 | $306M | Sell |
975,992
-212,583
| -18% | -$62.9M | 0.09% | 215 |
|
|
2017
Q2 | $323M | Buy |
1,188,575
+43,079
| +4% | +$11.4M | 0.1% | 201 |
|
|
2017
Q1 | $313M | Buy |
1,145,496
+182,345
| +19% | +$51.6M | 0.1% | 198 |
|
|
2016
Q4 | $273M | Sell |
963,151
-122,736
| -11% | -$36.4M | 0.1% | 219 |
|
|
2016
Q3 | $340M | Buy |
1,085,887
+11,297
| +1% | +$3.35M | 0.13% | 177 |
|
|
2016
Q2 | $260M | Buy |
1,074,590
+239,557
| +29% | +$63.1M | 0.1% | 215 |
|
|
2016
Q1 | $217M | Buy |
835,033
+55,808
| +7% | +$14.7M | 0.09% | 260 |
|
|
2015
Q4 | $239M | Sell |
779,225
-502,027
| -39% | -$144M | 0.09% | 246 |
|
|
2015
Q3 | $374M | Sell |
1,281,252
-948,108
| -43% | -$313M | 0.16% | 153 |
|
|
2015
Q2 | $901M | Sell |
2,229,360
-178,830
| -7% | -$71.8M | 0.35% | 48 |
|
|
2015
Q1 | $1.02B | Sell |
2,408,190
-303,123
| -11% | -$119M | 0.4% | 33 |
|
|
2014
Q4 | $920M | Buy |
2,711,313
+18,842
| +0.7% | +$6.1M | 0.36% | 44 |
|
|
2014
Q3 | $891M | Buy |
2,692,471
+186,419
| +7% | +$61.5M | 0.37% | 39 |
|
|
2014
Q2 | $790M | Buy |
2,506,052
+96,081
| +4% | +$28.9M | 0.33% | 52 |
|
|
2014
Q1 | $737M | Buy |
2,409,971
+275,909
| +13% | +$87.6M | 0.31% | 56 |
|
|
2013
Q4 | $597M | Buy |
2,134,062
+154,502
| +8% | +$40M | 0.26% | 82 |
|
|
2013
Q3 | $477M | Buy |
1,979,560
+46,785
| +2% | +$10.5M | 0.23% | 101 |
|
|
2013
Q2 | $416M | Buy |
+1,932,775
| New | +$413M | 0.22% | 105 |
|
Other funds holding BIIB
VCM
VPM
Wells Fargo's BIIB Position: Q1 2026 in Review
Wells Fargo increased its Biogen (BIIB) stake by 6.5% in Q1 2026, buying an estimated $1.44M and bringing the position to 127,134 shares worth $23.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1414.
Wells Fargo first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Wells Fargo held 127,134 shares of Biogen worth $23.3M as of Q1 2026.
- Wells Fargo bought 7,796 Biogen shares in Q1 2026, an estimated $1.44M.
- Biogen made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1414 holding.
- Wells Fargo first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Biogen position peaked at $1.02B in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.